Sodium Acetate
- Product NDC
- 0641-6262
- 11-digit product format
- 006416262
- Labeler code
- 0641
- Product ID
- 0641-6262_777b7564-f07b-401a-a042-0cd512ae3b25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sodium Acetate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA216920
- Marketing category
- ANDA
- Marketing start
- 2024-05-20
- Substance
- SODIUM ACETATE ANHYDROUS
- Active strength
- 164 mg/mL
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| NVG71ZZ7P0 | SODIUM ACETATE ANHYDROUS | 127-09-3 | SODIUM ACETATE ANHYDROUS |
| 4550K0SC9B | SODIUM ACETATE | 6131-90-4 | Sodium Acetate |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0641-6262-01 | 00641626201 | 1 VIAL in 1 CARTON (0641-6262-01) / 50 mL in 1 VIAL | 1 vial | 2024-05-20 | No | No | Historical |